Ruth Exner

2.4k total citations
45 papers, 1.0k citations indexed

About

Ruth Exner is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Ruth Exner has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 18 papers in Cancer Research and 13 papers in Surgery. Recurrent topics in Ruth Exner's work include Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (8 papers) and Breast Implant and Reconstruction (7 papers). Ruth Exner is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (8 papers) and Breast Implant and Reconstruction (7 papers). Ruth Exner collaborates with scholars based in Austria, Lithuania and Germany. Ruth Exner's co-authors include Barbara Wessner, N. Manhart, Florian Fitzal, Erich Roth, Andreas Spittler, Rudolf Oehler, Michael Gnant, Eva-Maria Strasser, R. Jakesz and Christian F. Singer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgery.

In The Last Decade

Ruth Exner

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Exner Austria 17 432 271 239 227 201 45 1.0k
Hakan Çamlıca Türkiye 22 526 1.2× 197 0.7× 198 0.8× 510 2.2× 171 0.9× 68 1.5k
Brian D. Lawenda United States 10 454 1.1× 199 0.7× 226 0.9× 137 0.6× 89 0.4× 19 986
Mamiko Kai Japan 13 296 0.7× 366 1.4× 264 1.1× 452 2.0× 129 0.6× 19 1.7k
Maria Ida Amabile Italy 19 264 0.6× 167 0.6× 203 0.8× 354 1.6× 90 0.4× 74 1.2k
Peter Libby United States 14 164 0.4× 158 0.6× 266 1.1× 395 1.7× 122 0.6× 22 1.7k
Carolyn R. Jonas United States 16 309 0.7× 96 0.4× 113 0.5× 366 1.6× 110 0.5× 23 1.2k
Simona D’Amore Italy 16 149 0.3× 110 0.4× 143 0.6× 266 1.2× 60 0.3× 56 752
Patrizia Mondello Italy 21 507 1.2× 89 0.3× 94 0.4× 372 1.6× 125 0.6× 80 1.3k
Jing Liang China 18 258 0.6× 107 0.4× 181 0.8× 295 1.3× 127 0.6× 73 1.0k
Hui Tian China 23 240 0.6× 369 1.4× 249 1.0× 683 3.0× 307 1.5× 95 1.4k

Countries citing papers authored by Ruth Exner

Since Specialization
Citations

This map shows the geographic impact of Ruth Exner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Exner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Exner more than expected).

Fields of papers citing papers by Ruth Exner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Exner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Exner. The network helps show where Ruth Exner may publish in the future.

Co-authorship network of co-authors of Ruth Exner

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Exner. A scholar is included among the top collaborators of Ruth Exner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Exner. Ruth Exner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frommlet, Florian, Oskar Koperek, Maximilian Marhold, et al.. (2025). HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 487(5). 1015–1024.
2.
Steindl, Ariane, Anna Grisold, Brigitte Gatterbauer, et al.. (2025). Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer. British Journal of Cancer. 132(8). 733–743.
3.
Bartsch, Rupert, Anna S. Berghoff, Julia Furtner, et al.. (2024). 187P Stage I results of a phase II study of datopotamab deruxtecan (DATO-DXd) in triple-negative breast cancer (TNBC) patients (pts) with active brain metastases (TUXEDO-2). ESMO Open. 9. 103209–103209. 4 indexed citations
4.
Exner, Ruth, et al.. (2023). The Impact of Adjuvant Radiotherapy on Immediate Prepectoral Implant-Based Breast Reconstruction. Aesthetic Plastic Surgery. 48(13). 2432–2438. 7 indexed citations
5.
Bergen, Elisabeth, Anna S. Berghoff, Margaretha Rudas, et al.. (2019). Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases. Clinical Cancer Research. 25(9). 2737–2744. 33 indexed citations
6.
Exner, Ruth, Florian Fitzal, Elisabeth Bergen, et al.. (2019). Utilization and performance of the Prosigna® breast cancer prognostic gene signature assay at the Medical University of Vienna. Annals of Oncology. 30. iii9–iii9. 1 indexed citations
7.
8.
Strobl, Stephanie, Kerstin Wimmer, Ruth Exner, et al.. (2018). Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer. Current Treatment Options in Oncology. 19(4). 18–18. 7 indexed citations
9.
Singer, Christian F., Yen Y. Tan, Florian Fitzal, et al.. (2017). Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer. Clinical Cancer Research. 23(14). 3676–3683. 32 indexed citations
10.
Krois, Wilfried, T. Cameron Wild, Peter Dubsky, et al.. (2017). Objective breast symmetry analysis with the breast analyzing tool (BAT): improved tool for clinical trials. Breast Cancer Research and Treatment. 164(2). 421–427. 21 indexed citations
11.
Bergen, Elisabeth, Anna S. Berghoff, Peter Dubsky, et al.. (2016). Prognostic impact of breast cancer subtypes in elderly patients. Breast Cancer Research and Treatment. 157(1). 91–99. 17 indexed citations
12.
Promberger, Regina, Peter Dubsky, Martina Mittlböck, et al.. (2015). Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy. Clinical Breast Cancer. 15(6). 505–511. 3 indexed citations
13.
Exner, Ruth, Walter Pulverer, Martin Schreiber, et al.. (2015). Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers. British Journal of Cancer. 113(7). 1035–1045. 23 indexed citations
14.
Exner, Ruth, Zsuzsanna Bagó-Horváth, Rupert Bartsch, et al.. (2014). The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2− early breast cancer. British Journal of Cancer. 111(5). 837–842. 23 indexed citations
15.
Exner, Ruth, Wilfried Krois, Martina Mittlböck, et al.. (2011). Objectively measured breast symmetry has no influence on quality of life in breast cancer patients. European Journal of Surgical Oncology. 38(2). 130–136. 15 indexed citations
16.
Blaha, Peter, Ruth Exner, Andrea Borgo, et al.. (2009). Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect Ratio. Breast Care. 4(3). 155–161. 2 indexed citations
17.
Götzinger, Peter, P. Wamser, Ruth Exner, et al.. (2003). Surgical Treatment of Severe Acute Pancreatitis: Timing of Operation is Crucial for Survival. Surgical Infections. 4(2). 205–211. 42 indexed citations
18.
Bergmann, Michael, et al.. (2003). Continuous Therapeutic Epinephrine but not Norepinephrine Prolongs Splanchnic IL-6 Production in Porcine Endotoxic Shock. Shock. 20(6). 575–581. 14 indexed citations
19.
Exner, Ruth, Dietmar Tamandl, Peter Goetzinger, et al.. (2003). Perioperative GLY-GLN Infusion Diminishes the Surgery-Induced Period of Immunosuppression. Annals of Surgery. 237(1). 110–115. 46 indexed citations
20.
Exner, Ruth, Maja Munk Eliasen, Christopher Gerner, et al.. (2002). Glutamine deficiency renders human monocytic cells more susceptible to specific apoptosis triggers. Surgery. 131(1). 75–80. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hakan Çamlıca Breakdown of academic impact, for papers by Brian D. Lawenda Breakdown of academic impact, for papers by Mamiko Kai Breakdown of academic impact, for papers by Maria Ida Amabile Breakdown of academic impact, for papers by Peter Libby Breakdown of academic impact, for papers by Carolyn R. Jonas Breakdown of academic impact, for papers by Simona D’Amore Breakdown of academic impact, for papers by Patrizia Mondello Breakdown of academic impact, for papers by Jing Liang Breakdown of academic impact, for papers by Hui Tian
Rankless by CCL
2026